Eduard Viladesau, Managing Director, HIPRA Biotech Services, highlights how the company brings engineered flexibility to the CDMO market.

The CDMO market is poised for growth due to rising R&D spending, increased demand for generics and biologics, patent ...

Dublin, April 10, 2018 (GLOBE NEWSWIRE) -- The "Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging" report has been added to ResearchAndMarkets.com's offering. The study ...

The "Contract Pharmaceutical Manufacturing, Research, and Packaging Market Forecasts to 2029" report has been added to ResearchAndMarkets.com's offering. This report aims to provide in-depth knowledge ...

South Korea-based LOTTE BIOLOGICS signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing PD1/VEGFR2 dual pathway antibodies ...

Contract development and manufacturing organizations (CDMOs) provide outsourcing options to biotechnology and pharmaceutical companies, helping them advance their drugs from the laboratory to the ...

HYDERABAD, Feb 29 (Reuters) - Indian contract drug manufacturer Suven Pharmaceuticals (SUVH.NS), opens new tab said on Thursday it will merge with Cohance Lifesciences in an all-share deal, as it ...

Ranjit Deshmukh, Principal, BiologixCMC, discusses how contract manufacturers can optimize their processes and plan for the future by optimizing facility design. Ranjit Deshmukh, who has 25 years of ...

After a rough regulatory start to the year, India’s Aurobindo Pharma is charting plans for growth. The Hyderabad-based generics juggernaut will plow 3 billion Indian rupees (about $37.7 million) into ...

Struggling to meet demand for CAR-T med Caryvkti, Johnson & Johnson and Legend Biotech have reached out to another cell therapy expert for help manufacturing their multiple myeloma treatment. Novartis ...

India's Piramal Pharma hopes to accelerate earnings growth over the next two to three years, led by rising demand for complex ...